Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
NVST 
Envista Holdings Corp (NVST)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/04/2025: NVST (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $22
1 Year Target Price $22
| 3 | Strong Buy |
| 0 | Buy |
| 10 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -22.32% | Avg. Invested days 43 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/04/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.35B USD | Price to earnings Ratio 223.67 | 1Y Target Price 22 |
Price to earnings Ratio 223.67 | 1Y Target Price 22 | ||
Volume (30-day avg) 14 | Beta 1.03 | 52 Weeks Range 14.22 - 22.68 | Updated Date 12/4/2025 |
52 Weeks Range 14.22 - 22.68 | Updated Date 12/4/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.09 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.58% | Operating Margin (TTM) 9.67% |
Management Effectiveness
Return on Assets (TTM) 2.66% | Return on Equity (TTM) 0.5% |
Valuation
Trailing PE 223.67 | Forward PE 16.39 | Enterprise Value 3786321381 | Price to Sales(TTM) 1.28 |
Enterprise Value 3786321381 | Price to Sales(TTM) 1.28 | ||
Enterprise Value to Revenue 1.44 | Enterprise Value to EBITDA 11.1 | Shares Outstanding 164426233 | Shares Floating 163768528 |
Shares Outstanding 164426233 | Shares Floating 163768528 | ||
Percent Insiders 0.51 | Percent Institutions 116.71 |
Upturn AI SWOT
Envista Holdings Corp
Company Overview
History and Background
Envista Holdings Corp. was formed in 2019 as a spin-off from Danaher Corporation. It focuses on dental products and technologies.
Core Business Areas
- Specialty Products & Technologies: Develops, manufactures, and markets a wide range of specialty products, including implants, orthodontic solutions, and biomaterials.
- Equipment & Consumables: Offers a portfolio of dental equipment, imaging systems, and consumables used by dentists and dental professionals.
Leadership and Structure
Amir Aghdaei is the CEO. The company operates with a decentralized structure across its various brands and business segments.
Top Products and Market Share
Key Offerings
- Competitors: Straumann, Dentsply Sirona, Zimmer Biomet
- Implants: Envista offers a range of dental implants under brands like Nobel Biocare, Implant Direct, and Kerr. Competitors include Straumann, Dentsply Sirona, and Zimmer Biomet. Precise market share data varies, but they are a significant player in the implant market. Revenue is bundled across multiple product lines and not specifically broken out.
- Competitors: Align Technology (Invisalign), 3M Unitek, Henry Schein Orthodontics
- Orthodontics: Ormco, a brand under Envista, provides orthodontic solutions like brackets, wires, and aligners. Competitors include Align Technology (Invisalign), 3M Unitek, and Henry Schein Orthodontics. Precise market share data varies, but they are a key player in orthodontics. Revenue is bundled across multiple product lines and not specifically broken out.
- Competitors: Dentsply Sirona, Carestream Dental, Planmeca
- Imaging Systems: Envista offers digital imaging systems and software through brands like KaVo and DEXIS, providing solutions for intraoral scanning and diagnostics. Competitors include Dentsply Sirona, Carestream Dental, and Planmeca. Precise market share data varies, but they are a player in the imaging systems market. Revenue is bundled across multiple product lines and not specifically broken out.
Market Dynamics
Industry Overview
The dental products and technologies industry is driven by factors such as an aging population, increasing awareness of oral hygiene, and technological advancements. It's a competitive market with global players and regional specialists.
Positioning
Envista Holdings Corp. is positioned as a leading provider of dental solutions, with a strong portfolio of brands and a global presence. They have a competitive advantage in their extensive product range and established distribution network.
Total Addressable Market (TAM)
The global dental market is estimated to be around $40-50 billion. Envista, with its diverse portfolio, is positioned to capture a significant portion of this market.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio (Nobel Biocare, Ormco, KaVo, DEXIS)
- Global presence and established distribution network
- Diversified product range
- Focus on innovation and technology
Weaknesses
- High debt levels (related to spin-off)
- Dependence on third-party distributors in some markets
- Complex organizational structure
- Integration risk related to acquisitions
Opportunities
- Expanding into emerging markets
- Developing new products and technologies
- Acquiring smaller companies to expand product portfolio
- Increasing adoption of digital dentistry
Threats
- Intense competition from established players
- Economic downturns impacting dental spending
- Changing regulatory landscape
- Technological disruption from new entrants
Competitors and Market Share
Key Competitors
- Dentsply Sirona (XRAY)
- Align Technology (ALGN)
- Straumann (STMN.SW)
Competitive Landscape
Envista has a broad product portfolio and global presence, but faces stiff competition from larger and more specialized players.
Major Acquisitions
Carestream Dental's Intraoral Scanner Business
- Year: 2024
- Acquisition Price (USD millions): 600
- Strategic Rationale: Expand digital dentistry portfolio and enhance position in intraoral scanning market.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by organic growth and acquisitions. Growth rates depend on prevailing economic conditions and demand for dental products and technologies.
Future Projections: Analyst projections for future growth vary and would depend on market conditions and company performance. A growth rate in the mid-single digits is a reasonable expectation.
Recent Initiatives: Recent initiatives include new product launches, acquisitions of complementary businesses, and investments in research and development.
Summary
Envista is a well-established dental products company with a diverse portfolio and global presence. Its strengths lie in its strong brands and distribution network, but it faces challenges related to debt, competition, and integration risks. Recent acquisitions should bolster its market position. Overall, Envista is a fundamentally sound company navigating a competitive landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings, analyst reports, industry publications
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envista Holdings Corp
Exchange NYSE | Headquaters Brea, CA, United States | ||
IPO Launch date 2019-09-18 | CEO & Director Mr. Paul A. Keel | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 12300 | Website https://envistaco.com |
Full time employees 12300 | Website https://envistaco.com | ||
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.